🇺🇸 Radium-223 chloride in United States
5 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 5
Most-reported reactions
- Anaemia — 1 report (20%)
- Drug Interaction — 1 report (20%)
- Drug Level Decreased — 1 report (20%)
- Leukopenia — 1 report (20%)
- Thrombocytopenia — 1 report (20%)
Other Oncology approved in United States
Frequently asked questions
Is Radium-223 chloride approved in United States?
Radium-223 chloride does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Radium-223 chloride in United States?
Amsterdam UMC, location VUmc is the originator. The local marketing authorisation holder may differ — check the official source linked above.